Literature DB >> 17622394

Would a national pharmaceutical strategy be bad for the cardiovascular health of Canadians?

Jack V Tu.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17622394      PMCID： PMC2651915          DOI： 10.1016/s0828-282x(07)70816-4

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


× No keyword cloud information.
  9 in total

1.  Heart attacks and unstable angina (acute coronary syndromes) have doubled in New Zealand since 1989: how do we best manage the epidemic?

Authors:  John Elliott; Mark Richards
Journal:  N Z Med J       Date:  2005-10-07

2.  Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.

Authors:  Zheng Zhou; Elham Rahme; Michal Abrahamowicz; Jack V Tu; Mark J Eisenberg; Karin Humphries; Peter C Austin; Louise Pilote
Journal:  CMAJ       Date:  2005-04-26       Impact factor: 8.262

3.  Is ramipril really better than other angiotensin-converting enzyme inhibitors after acute myocardial infarction?

Authors:  Karen Tu; Nadia Gunraj; Muhammad Mamdani
Journal:  Am J Cardiol       Date:  2006-04-27       Impact factor: 2.778

4.  Heart health has an adverse future forecast in New Zealand: an alarm call to action across the continuum.

Authors:  Norman Sharpe
Journal:  N Z Med J       Date:  2006-04-21

5.  Adverse events associated with prescription drug cost-sharing among poor and elderly persons.

Authors:  R Tamblyn; R Laprise; J A Hanley; M Abrahamowicz; S Scott; N Mayo; J Hurley; R Grad; E Latimer; R Perreault; P McLeod; A Huang; P Larochelle; L Mallet
Journal:  JAMA       Date:  2001 Jan 24-31       Impact factor: 56.272

Review 6.  Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.

Authors:  Zheng Zhou; Elham Rahme; Louise Pilote
Journal:  Am Heart J       Date:  2006-02       Impact factor: 4.749

7.  Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

Authors:  Sebastian Schneeweiss; Alexander M Walker; Robert J Glynn; Malcolm Maclure; Colin Dormuth; Stephen B Soumerai
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

8.  Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

Authors:  S B Soumerai; T J McLaughlin; D Ross-Degnan; C S Casteris; P Bollini
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

9.  Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.

Authors:  Sebastian Schneeweiss; Stephen B Soumerai; Malcolm Maclure; Colin Dormuth; Alexander M Walker; Robert J Glynn
Journal:  Clin Pharmacol Ther       Date:  2003-10       Impact factor: 6.875
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.